<DOC>
	<DOCNO>NCT00443534</DOCNO>
	<brief_summary>This protocol allow subject participate previous SU011248 protocol ability continue receive SU011248 study end .</brief_summary>
	<brief_title>A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol .</brief_title>
	<detailed_description />
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Participation previous SU011248 protocol judge investigator potential derive clinical benefit remain SU011248 prior protocol end . Severe acute chronic medical psychiatric condition , laboratory abnormality may increase risk associate study participation study drug administration , may interfere interpretation study result , judgment investigator would make patient inappropriate entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>